IPO Detail
Sai Life Sciences Limited
MAINBOARDNot investment advice. Read RHP before applying.
Overview
About the Company
Sai Life Sciences Limited is a renowned player operating in the Pharma Research (CRDMO) industry with extensive operational footprint across India.
New to IPO analysis? You may review our structured guides on how IPO allotment works and IPO subscription meaning to better understand demand and allocation mechanics.
Issue
IPO Issue Details
Issue Price
₹544 – ₹549
Face Value
₹10
Issue Size
3042.62
Fresh Issue
2129.83
Listing At
NSE, BSE
Lead Manager
Kotak Mahindra Capital, Axis Capital, ICICI Securities
Registrar
Link Intime India Private Ltd
Lot Size
27
For category-wise quota breakdown such as QIB, HNI, and Retail allocation, refer to our IPO quota structure explanation.
Milestones
Timeline
If you are tracking GMP alongside subscription demand, see our grey market premium guide for a structured comparison framework.
Subscription
Live Subscription Details
Subscription Progress
Subscription data sourced from exchange updates. Values represent times subscribed (x).
Learn how subscription categories are allocated by reading our guide on QIB, HNI and Retail IPO quota structure.
If you are tracking GMP alongside subscription demand, see our grey market premium guide for a structured comparison framework.
Allotment Probability Calculator
SEBI-compliant allotment prediction based on live subscription data.
Chance of Allotment
6.2%
The Retail category is oversubscribed by 16.10x. Under SEBI rules, allotment is done via a draw of lots (lottery). Every successful applicant gets a maximum of 1 lot, regardless of how many lots they applied for.
GMP (Grey Market Premium)
GMP Overview
₹120
Updated —
+21.9% over issue price
GMP is unofficial and indicative only. It does not guarantee listing price or returns.
GMP is unofficial and indicative. To understand interpretation logic and limitations, read our IPO Grey Market Guide or begin with what IPO GMP means.
Trend
GMP Trend
No GMP data yet. Updates will appear once available.
Investment
Market Lot Details
Investors can bid in multiples of the lot size. Final investment depends on the cutoff price.
Allocation
Reservation Details
QIB
50%
NII
15%
RII
50%
Employee
—
Issue Summary
Objectives of Issue
- 1.Funding expansion and capital expenditure requirements.
- 2.General corporate purposes and strategic initiatives.
Financials
Key Financial Metrics
EPS Pre IPO
23.5
EPS Post IPO
19.1
P/E Pre
26.4
P/E Post
32.8
ROCE
25.5%
Debt / Equity
0.74
PAT Margin
20.4%
Market Cap
12779.0
Financial figures sourced from official offer documents. Always verify with the RHP.
Ownership
Promoter Holdings
Pre Issue
76.50%
Post Issue
64.20%
Contacts
Company & Registrar Details
Company Address: Registered Office, Industrial Development Zone, India
Phone: +91-22-4000-8000
Email: investor@sai-life-sciences.com
Website: https://www.sai-life-sciences.com
Registrar: Link Intime India Private Ltd
Registrar Phone: +91-22-4918-6270
Registrar Email: ipo.help@sai-life-sciences.com
Registrar Website: https://linkintime.co.in
Documents
Important Links
Performance
Listing Performance
Listing Exchange
NSE, BSE
Listing Price
₹724.68
Listing Gain
32%
Pre-Listing Prediction
Est. Gain: 21.86%|Actual Gain: 32.00%
Application
How to Apply
UPI Method (ASBA)
Log in to your broker's app or net banking, navigate to the IPO section, select this IPO, enter lot quantity, and authorise via UPI mandate. Funds are blocked, not debited, until allotment.
ASBA via Net Banking
Log in to your bank's net banking portal, go to the IPO / ASBA section, fill in the bid details, and submit. Your bank will block the required amount automatically.
Allotment & Refund
Allotment status is typically available within 6 days of the IPO close date. Refunds for unallotted bids are credited within 2 working days post allotment.
You may also review the complete IPO allotment process explanation to understand lottery mechanics and refund timelines.
Qualitative Factors
Strengths & Risks
Company Strengths
- 1.Strong position in the Pharma Research (CRDMO) sector.
- 2.Robust revenue growth with experienced management team.
Company Risks
- 1.Subject to sector regulatory policies and raw material price movements.
Legal Disclaimer
Information is sourced from publicly available exchange filings and company offer documents. GMP is unofficial and indicative. IPOCraft does not provide investment advice.
Research Before You Apply